Interestingly, Hernandez et al. [49] demonstrated that dicumarol down-regulated PTTG1 expression in HCT116 colon cancer cells at least in part through inhibition of Hsp90 and the consequent impairment of the RAS/RAF/MEK/ERK signaling pathway. This evidence concerns the gene MAP2K7 and malignant colon neoplasm.